Crodafos™ CES pharma
Product Description
Croda pharma
-
GB
-
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
Categories
Croda pharma
-
GB
-
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
More Products from Croda pharma (26)
-
Product Excipient: Super Refined™ Polysorbate 20
Super Refined Polysorbates solubilise and stabilise the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, helping to red... -
Product Vaccine Adjuvant: Alhydrogel™
• Alhydrogel is a range of aluminium hydroxide gel products which have been specifically developed for use as an adjuvant in human and veterinary vaccines • The gel is a suspension of boehmite-like (aluminium oxyhydroxide) hydrated nano/micron size crystals in loose aggregates • The products have v... -
Product Excipient: Super Refined™ DEGEE
Super Refined DEGEE is ideal for use in topical and transdermal applications to enhance the permeation of poorly water-soluble API’s through various layers of the skin, thereby improving drug delivery. It can also be used as a co-solvent in self-emulsifying drug delivery systems (SEDDS), or self-microe... -
Product Excipient: Super Refined™ P35 Caster Oil
Super Refined P35 Castor Oil is a castor oil derivative, resulting from the reaction of glycerol ricinoleate and 35 mols of ethylene oxide. This product is a liquid nonionic solubiliser and emulsifier, characteristic of a slightly yellow hue, and is intended for use in parenteral, ophthalmic, oral, and... -
Product Vaccine Adjuvant: Quil-A™
• Quil-A is a highly purified and concentrated saponin adjuvant purified from bark extract of the Quillaja saponaria Molina tree which has been specifically developed for use as an adjuvant in vaccines • Quil-A saponin was originally purified and characterised by Dr. Pharm • Kristian Dalsgaard in 1... -
Product Cholesterol
W/O emulsifier, emulsion stabiliser and moisturiser with skin conditioning and barrier repair benefits. High purity grade also available. Recommended topical usage levels of 0.5-5%. Cholesterol in the free and combined state is the most widely occurring sterol in animal tissue. It is an essential compound ... -
Product Super Refined™ DMI
Super Refined DMI is a highly purified solubiliser, epidermal penetration enhancer and spreading agent. Applications include topical anti-inflammatory drug delivery, scalp treatments and anti-acne treatments. -
Product ALC-0159
ALC-0159 is a polyethylene glycol (PEG)-lipid conjugate also called a PEGylated lipid.
ALC-0159 is a lipid excipient that can be used to form lipid nanoparticles (LNPs). -
Product ALC-0315
ALC-0315 is an ionizable cationic lipid used in combination with other lipids to form lipid nanoparticles (LNPs). -
Product Cationic Adjuvant Formulation CAF®
Croda Pharma continuously increases its offering in innovative vaccine adjuvant systems. The strategic collaboration with SSI (Statens Serum Institut, leading Danish governmental life-science research institute) enables us to offer an even more diverse adjuvant portfolio.
The CAF® t... -
Product ENT-DSPC
Ent-DSPC/Ent-2,3-Distearoyl-sn-Glycero-1-Phosphocholine is an enantiomer of the compound DSPC/2,3-distearoyl-sn-glycero-1-phosphocholine.
Enantiomers are also known as optical isomers, optical antipodes, or just antipodes. They are pairs of non-superimposable mirror forms of one another. Enantio... -
Product Super Refined™ Benzyl Alcohol
Super Refined™ Benzyl Alcohol: Super Refined™ Benzyl Alcohol is a high purity aromatic alcohol suitable for use as a preservative, solvent, and viscosity reducing agent. Boasting benefits such as very low benzaldehyde and peroxide levels, Super Refined Benzyl Alcohol meets the requirements for injecta...
Croda pharma resources (2)
-
News Two new partnerships to drive sustainable delivery systems for the pharmaceutical industry
Croda International Plc (Croda) today announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain for vaccine adjuvants. -
Brochure Addressing the challenges of vaccine formulation
To this day, our focus has been to successfully develop, manufacture and market high-quality adjuvants for our pharmaceutical customers. This heritage makes our vaccine adjuvants unique in the industry. A heritage we are proud of.
Our industry-leading, Alhydrogel®, Adju-Phos® and Quil-A® are widely recognised in the vaccine industry for their unmatched track record when it comes to a proven history of safe and effective use.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance